- Tytuł:
- Corrigendum to “Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease” [Dig. Liver Dis. 48 (2016) 360–370]
- Autorzy:
- Źródło:
- In Digestive and Liver Disease September 2016 48(9):1103-1103
Czasopismo naukowe